Ultimately, the defining feature of PACG in individuals with glaucomatous optic nerve damage is iridocorneal angle closure. Recently, COL18A1 which encodes collagen type XVIII was identified as a gene that affects angle closure in patients of three unrelated families. [17] The inheritance pattern of angle closure causing mutations in COL18A1 was autosomal dominant. It appears that mutations in this gene may cause angle closure in the fourth decade of life or later. Furthermore, COL18A1 mutations are not expected to be a common cause of angle closure-related phenotypes. The significance of having identified COL18A1 as a potential PACG-causing gene lies in emphasis on the importance of collagens and the extracellular matrix in glaucoma pathology.
In pursuit of identifying genes that contribute to PACG disease, association studies and candidate gene studies have been performed and the results of these have implicated possible roles for several genes. [18] [19] [20] [21] [22] [23] [24] [25] However, these findings are not generally considered definitive, and putative roles of genes suggested by some studies were not confirmed in independent studies. Factors known to be associated with PACG include hyperoptic refractive error, shallow anterior chamber, thick crystalline lens, short axial length, small corneal diameter, and narrow iridocorneal angle. [26] [27] [28] Clearly, some of these also associate with each other. In an article published in this issue of the Journal of Ophthalmic and Vision Research, the authors relied on transcriptome data pertaining to eye anterior segment tissues to select five single nucleotide polymorphisms (SNPs) whose genotypes may be associated with PACG among patients of Northeast Iran. [29] [30] [31] Interestingly, one of the SNPs for which an association with PACG was reported is positioned in a gene (FERMT2) that encodes a component of the ECM. Results of an association study that included tens of thousands of patients and controls had also implicated the same gene with respect to PACG. [20] There exists accumulating evidence that implicates various collagens specifically and the extracellular matrix more generally in the pathogenesis of glaucoma. [7, [32] [33] [34] [35] [36] Eight loci were identified in one or both of two recent large genome-wide association (GWA) studies on PACG patients, and COL11A1 that encodes one of the alpha chains of type XI collagen was one of the genes identified in both of the studies. [18, 20] An SNP in COL1A1 was associated with increased risk of myopia in Japanese and Chinese individuals. [37, 38] A GWA study of PACG in a dog breed identified COL1A2 as a susceptibility locus. [39] And of course, COL18A1 was identified as a gene that affects iridocorneal angle closure in humans. [17] In addition to collagens, genes with roles in the extracellular matrix and also associated with glaucoma include MMP-9, MTHFR, LTBP2, CYP1B1, and SPARC. It has been suggested that inter-individual differences in tolerance to IOP as reflected in glaucoma diagnosis with normal tension in some and ocular hypertension without glaucoma in others reflect variations in biomechanical properties of the extracellular matrix of relevant ocular tissues. [32] 
